Malpractice Litigation in Pediatric Ophthalmology

Stephanie B Engelhard1, Megan Collins2, Christopher Shah1

  • 1Department of Ophthalmology, University of Virginia, Charlottesville.

JAMA Ophthalmology
|September 2, 2016
PubMed

Insights

Pediatric ophthalmology malpractice cases are more likely to favor the plaintiff and result in higher awards than adult cases. Conditions like retinopathy of prematurity and legal blindness are common in these litigations.

Area of Science:

  • Ophthalmology
  • Medical Law
  • Pediatric Medicine

Background:

  • Understanding malpractice litigation outcomes is crucial for ophthalmologists to improve patient care and prevent lawsuits.
  • Pediatric malpractice cases present unique challenges and outcomes compared to adult cases.

Purpose of the Study:

  • To analyze the causes and outcomes of ophthalmology medical malpractice litigation involving patients under 18 years old.
  • To compare pediatric malpractice cases with those involving adult patients.

Main Methods:

  • A comprehensive review of the WestLaw database was conducted for ophthalmology malpractice cases from 1930 to 2014.
  • Cases involving plaintiffs younger than 18 years at the time of the event were identified and analyzed.
  • Pediatric cases were compared to adult cases regarding verdicts and settlement amounts.

Main Results:

  • Sixty-eight pediatric ophthalmology malpractice cases were included; 48.6% resulted in plaintiff verdicts, significantly higher than adult cases (28.8%).
  • Mean jury awards in pediatric cases were substantially higher than in adult cases ($4,815,693 vs. $3,422,134 difference).
  • Common causes included traumatic ocular injury, retinopathy of prematurity, and endophthalmitis, with retinopathy of prematurity cases yielding the highest payments.

Conclusions:

  • Ophthalmology malpractice litigation involving pediatric patients is more frequently resolved in favor of the plaintiff and associated with higher monetary awards.
  • Cases involving retinopathy of prematurity, legal blindness, and endophthalmitis were more likely to result in plaintiff-favorable outcomes.
  • This analysis provides critical insights for pediatric ophthalmologists regarding high-risk scenarios and conditions that may lead to litigation.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
304
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
292
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
223
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
259